Donald Trump's Name is Everywhere — But What Does He Actually Own?

Donald Trump's Name is Everywhere — But What Does He Actually Own?

President-elect Donald Trump likes to put his name on things. The Trump brand has appeared on everything from steaks to vodka, hotels, golf courses, residential buildings, his ill-fated university, casinos, and a whole lot more. But, just because a product or building carries the Trump brand does not mean that the soon-to-be-leader-of-the-free-world actually owns it. → Read More

2 Ways Home Depot Inc. Just Trounced Rival Lowe's

2 Ways Home Depot Inc. Just Trounced Rival Lowe's

Investors are grading Home Depot (NYSE:HD) on a curve. The company is posting growth that puts other national retailers to shame. Its profitability is soaring, too. And yet, Home Depot is one of just four members of the Dow that are trading lower so far in 2016. One driver behind the stock price disconnect is → Read More

Alliance Holdings GP Is Running Out of Room to Grow…What's Next?

Alliance Holdings GP Is Running Out of Room to Grow…What's Next?

Alliance Holdings GP, L.P. (NASDAQ:AHGP) is the general partner of Alliance Resource Partners, L.P. (NASDAQ:ARLP). In simple terms that means Alliance Holdings runs Alliance Resource Partners’ coal business. That looks like a dying business…or is it? Here’s what’s next for the coal miner. The relationship To understand Alliance Holdings GP, you first have to understand → Read More

Cheesecake Factory Gets Hungry Again

Cheesecake Factory Gets Hungry Again

If Cheesecake Factory (NASDAQ:CAKE) ever needs a fourth — or a fifth — act it may already have it in its back pocket. The company behind the high-volume namesake restaurant chain entered into a strategic relationship with Fox Restaurant Concepts on Monday. Cheesecake Factory is making an initial minority equity investment in Fox’s North Italia and → Read More

3 Things Exelixis Must Do to Survive and Thrive in 2017

3 Things Exelixis Must Do to Survive and Thrive in 2017

Few stocks have performed as well as Exelixis (NASDAQ:EXEL) has in 2016. The biotech’s share price has nearly tripled this year. Will Exelixis be able to carry this tremendous momentum in to 2017? Mike Morrissey, Exelixis’ CEO, spoke at the Stifel Healthcare Conference this week and laid out his view of the biotech’s opportunities and → Read More

3 Great Stocks for Your Roth IRA

3 Great Stocks for Your Roth IRA

While you won’t get a tax deduction for contributing to a Roth IRA, your future self will thank you. Your money grows tax-free in a Roth IRA, and distributions after reaching the required age go straight into your pocket without Uncle Sam taking a cut. This setup makes buying dividend stocks a great Roth IRA → Read More

3 Compelling Reasons to Buy Celgene Corporation Stock Right Now

3 Compelling Reasons to Buy Celgene Corporation Stock Right Now

If I didn’t already own shares of Celgene (NASDAQ:CELG), it would probably be the top stock on my list to buy. There are plenty of reasons why buying this biotech stock makes sense, including sustained growth of its blockbuster blood cancer drug. But Celgene isn’t just about Revlimid. Here are three compelling reasons to buy → Read More

Play this coding game. Score a job in Silicon Valley

Play this coding game. Score a job in Silicon Valley

Inside this laundromat there’s a coding school It took less than three months for an online coding game to transform James Johnston’s life. Johnston, 31, was designing software for orthodontists and living in Chattanooga, Tennessee, when he landed a better-paid software engineering job in Silicon Valley at a major tech startup. The key to this → Read More

Apple, Inc.'s Strange Fascination With Original Content Is Misplaced and Noncommittal

Apple, Inc.'s Strange Fascination With Original Content Is Misplaced and Noncommittal

It’s been about nine months since we first heard about Vital Signs, Apple‘s (NASDAQ:AAPL) rumored foray into original TV content that would be based on hip-hop-artist-turned-Apple-executive Dr. Dre. We haven’t heard much about the project since, but there have been various other headlines and rumors that form a mosaic around Apple’s interest in original content. → Read More

How this Cuban immigrant became a Spanish-language radio mogul

How this Cuban immigrant became a Spanish-language radio mogul

Once a child refugee of the Cuban Revolution, Raul Alarcón, Jr. had big dreams growing up. He wanted to become a doctor. He studied pre-med at Fordham University. But medical school — and a career in the medical profession — weren’t in the cards. Instead, Alarcón took a much different turn. He helped his father → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.